Nystatin
Brand name: Nystatin
Rank #411 of 500 drugs by total cost
$21.4M
Total Cost
908,177
Total Claims
$21.4M
Total Cost
38,472
Prescribers
$24
Cost per Claim
323,054
Beneficiaries
950,839
30-Day Fills
$555
Avg Cost/Provider
24
Avg Claims/Provider
About Nystatin
Nystatin (sold as Nystatin) was prescribed 908,177 times by 38,472 Medicare Part D providers in 2023, costing the program $21.4M. At $24 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 408 | Asciminib Hydrochloride (Scemblix) | $21.4M | 830 |
| 409 | Cephalexin (Cephalexin) | $21.4M | 2,407,718 |
| 410 | Teprotumumab-Trbw (Tepezza) | $21.4M | 389 |
| 411 | Nystatin (Nystatin) | $21.4M | 908,177 |
| 412 | Desvenlafaxine Succinate (Desvenlafaxine Succinate Er) | $21.3M | 257,580 |
| 413 | Sotorasib (Lumakras) | $21.3M | 1,188 |
| 414 | Ibuprofen (Ibuprofen) | $21.2M | 2,537,634 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology